This is an introductory course which should meet the needs of a wide variety of practitioners.
The course is aimed at personnel concerned with the safe use of medicines, particularly in developed countries, including those working (or intending to work) in: the pharmaceutical industry who are involved in drug development, licensing, and surveillance; regulatory bodies who are involved in licensing and surveillance; the health service who are involved in drug policy; and health policy decision-making agencies.
By the end of this course, you’ll be able to:
- Evaluate issues surrounding the risks and benefits of drug use in humans, including the cause and effects of adverse drug effects.
- Compare statistical, economic and epidemiological concepts and methods.
- Reflect upon how pharmacoepidemiological methods can be applied to specific drug issues.
- Analyse and appraise pharmacoepidemiological studies and their results.
- Understand the cost-effectiveness assessment for new medicines.
- Use your learning alongside your experience to produce an evaluative project.